Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Whelan

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancer Immunology, Immunotherapy : CII|September 15, 2005
The biological effects of syngeneic and allogeneic cytokine-expressing prophylactic whole cell vaccines and the influence of irradiation in a murine melanoma modelMarie-Christine Labarthe, Nicole Halanek, Lindsay Birchall, et al.
Vaccine|July 13, 2020
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccinesSonali Kochhar, Denny Kim, Jean-Louis Excler, et al.
Vaccine|August 5, 2020
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccinesSonali Kochhar, Jean-Louis Excler, Denny Kim, et al.
Vaccine|October 19, 2020
Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccinesMarc Gurwith, Richard C Condit, Jean-Louis Excler, et al.
Plos One|April 2, 2015
Tandem fusion of hepatitis B core antigen allows assembly of virus-like particles in bacteria and plants with enhanced capacity to accommodate foreign proteinsHadrien Peyret, Annick Gehin, Eva C Thuenemann, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|November 29, 2019
Developing vaccines against epidemic-prone emerging infectious diseasesValentina Bernasconi, Paul A Kristiansen, Mike Whelan, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|January 10, 2020
Correction to: Developing vaccines against epidemic-prone emerging infectious diseasesValentina Bernasconi, Paul A Kristiansen, Mike Whelan, et al.
Hepatology (Baltimore, Md.)|February 28, 2007
Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicityChristine S Rollier, Glaucia Paranhos-Baccala, Ernst J Verschoor, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Immunology, Immunotherapy : CII|September 15, 2005
The biological effects of syngeneic and allogeneic cytokine-expressing prophylactic whole cell vaccines and the influence of irradiation in a murine melanoma modelMarie-Christine Labarthe, Nicole Halanek, Lindsay Birchall, et al.
Vaccine|July 13, 2020
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccinesSonali Kochhar, Denny Kim, Jean-Louis Excler, et al.
Vaccine|August 5, 2020
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccinesSonali Kochhar, Jean-Louis Excler, Denny Kim, et al.
Vaccine|October 19, 2020
Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccinesMarc Gurwith, Richard C Condit, Jean-Louis Excler, et al.
Plos One|April 2, 2015
Tandem fusion of hepatitis B core antigen allows assembly of virus-like particles in bacteria and plants with enhanced capacity to accommodate foreign proteinsHadrien Peyret, Annick Gehin, Eva C Thuenemann, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|November 29, 2019
Developing vaccines against epidemic-prone emerging infectious diseasesValentina Bernasconi, Paul A Kristiansen, Mike Whelan, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|January 10, 2020
Correction to: Developing vaccines against epidemic-prone emerging infectious diseasesValentina Bernasconi, Paul A Kristiansen, Mike Whelan, et al.
Hepatology (Baltimore, Md.)|February 28, 2007
Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicityChristine S Rollier, Glaucia Paranhos-Baccala, Ernst J Verschoor, et al.
Pageof 2